Updated recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19

The interim recommendations  for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) have been updated to reflect latest evidence.

For further information, see here.


Tags assigned to this article:

You may have an interest in also reading…

UN chief to press G20 for greater solidarity and support during pandemic

When he addresses leaders of the world’s richest countries at the G20 summit this weekend, UN Secretary-General António Guterres will

IMF Blog: Putting Public Investment to Work

By Mariano Moszoro For countries on the path to recovery, reviving economic activity is a major priority. And what better way

Latest results from a UN-coordinated international trial on four COVID-19 therapeutic drugs, indicate that they have “little or no” positive impact on preventing deaths in patients